Frank Derek S, Matzger Adam J
Department of Chemistry and the Macromolecular Science and Engineering Program, The University of Michigan, 930 North University Avenue, Ann Arbor, Michigan 48109-1055, United States.
Cryst Growth Des. 2017;17(8):4056-4059. doi: 10.1021/acs.cgd.7b00593. Epub 2017 Jun 23.
Polymer-induced heteronucleation can dramatically increase the nucleation rate of pharmaceuticals. However, directly comparing the heteronucleation rates of different polymer functionalities is often convoluted with changing physical or structural aspects of heteronuclei. Here, we report a methodology for comparing nucleation efficiencies of different functionalities on polymer heteronuclei of uniform topology with the goal of identifying those functionalities that best accelerate nucleation of a model pharmaceutical. It was found that the previously employed design for additives to speed acetaminophen crystallization underperforms a modified framework that accounts for the effect of competitive solvent binding. These findings are informed by a survey of interactions from the CSD and not only serve to aid in the controlled crystallization of pharmaceuticals, but also provide insight into the mechanism of heteronucleation.
聚合物诱导的异相成核可显著提高药物的成核速率。然而,直接比较不同聚合物官能团的异相成核速率往往因异质核物理或结构方面的变化而变得复杂。在此,我们报告一种方法,用于比较具有均匀拓扑结构的聚合物异质核上不同官能团的成核效率,目的是识别那些最能加速模型药物成核的官能团。研究发现,先前用于加速对乙酰氨基酚结晶的添加剂设计不如一种改进的框架,该框架考虑了竞争性溶剂结合的影响。这些发现是基于对剑桥晶体结构数据库(CSD)中相互作用的调查得出的,不仅有助于药物的可控结晶,还能深入了解异相成核的机制。